Michaeli JC, Michaeli T, Trapani D, Albers S, et al. Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits,
innovation, trials, endpoints, quality of life, value, and price. Breast Cancer 2024 Sep 25. doi: 10.1007/s12282-024-01634.
PMID: 39320645
|